Pflug Koory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.5K | Hold |
115
| – | – | 0.01% | 284 |
|
|
2025
Q4 | $20K | Hold |
115
| – | – | 0.01% | 290 |
|
|
2025
Q3 | $21.9K | Hold |
115
| – | – | 0.01% | 281 |
|
|
2025
Q2 | $20.7K | Hold |
115
| – | – | 0.01% | 284 |
|
|
2025
Q1 | $19.5K | Hold |
115
| – | – | 0.01% | 284 |
|
|
2024
Q4 | $17.3K | Hold |
115
| – | – | 0.01% | 296 |
|
|
2024
Q3 | $17.9K | Buy |
+115
| New | +$17.2K | 0.01% | 293 |
|
|
2024
Q1 | $15.3K | Hold |
115
| – | – | 0.01% | 300 |
|
|
2023
Q4 | $15.9K | Hold |
115
| – | – | 0.01% | 298 |
|
|
2023
Q3 | $14K | Hold |
115
| – | – | 0.01% | 294 |
|
|
2023
Q2 | $16.2K | Hold |
115
| – | – | 0.01% | 295 |
|
|
2023
Q1 | $16.3K | Hold |
115
| – | – | 0.01% | 297 |
|
|
2022
Q4 | $18K | Sell |
115
-117
| -50% | -$16.8K | 0.01% | 294 |
|
|
2022
Q3 | $28K | Hold |
232
| – | – | 0.02% | 270 |
|
|
2022
Q2 | $31K | Hold |
232
| – | – | 0.02% | 272 |
|
|
2022
Q1 | $32K | Hold |
232
| – | – | 0.02% | 285 |
|
|
2021
Q4 | $40K | Hold |
232
| – | – | 0.02% | 277 |
|
|
2021
Q3 | $34K | Hold |
232
| – | – | 0.02% | 283 |
|
|
2021
Q2 | $31K | Hold |
232
| – | – | 0.02% | 290 |
|
|
2021
Q1 | $30K | Hold |
232
| – | – | 0.02% | 283 |
|
|
2020
Q4 | $28K | Hold |
232
| – | – | 0.02% | 278 |
|
|
2020
Q3 | $27K | Buy |
232
+42
| +22% | +$4.96K | 0.02% | 258 |
|
|
2020
Q2 | $22K | Hold |
190
| – | – | 0.02% | 266 |
|
|
2020
Q1 | $15K | Sell |
190
-100
| -34% | -$10.4K | 0.01% | 273 |
|
|
2019
Q4 | $31K | Hold |
290
| – | – | 0.02% | 257 |
|
|
2019
Q3 | $31K | Hold |
290
| – | – | 0.02% | 254 |
|
|
2019
Q2 | $30K | Hold |
290
| – | – | 0.02% | 250 |
|
|
2019
Q1 | $26K | Sell |
290
-50
| -15% | -$4.33K | 0.02% | 263 |
|
|
2018
Q4 | $28K | Hold |
340
| – | – | 0.02% | 245 |
|
|
2018
Q3 | $37K | Hold |
340
| – | – | 0.03% | 236 |
|
|
2018
Q2 | $37K | Hold |
340
| – | – | 0.03% | 233 |
|
|
2018
Q1 | $34K | Buy |
340
+25
| +8% | +$2.56K | 0.03% | 234 |
|
|
2017
Q4 | $31K | Hold |
315
| – | – | 0.02% | 238 |
|
|
2017
Q3 | $29K | Sell |
315
-40
| -11% | -$4.25K | 0.02% | 249 |
|
|
2017
Q2 | $39K | Hold |
355
| – | – | 0.03% | 233 |
|
|
2017
Q1 | $35K | Hold |
355
| – | – | 0.03% | 229 |
|
|
2016
Q4 | $33 | Buy |
+355
| New | +$30.6K | 0.03% | 222 |
|
Other funds holding DGX
VCM
VPM
EIG
Pflug Koory's DGX Position: Q1 2026 in Review
Pflug Koory held its Quest Diagnostics (DGX) position steady in Q1 2026 at 115 shares worth $22.5K. The position accounts for 0.01% of the portfolio, ranked #284.
Pflug Koory first reported a position in DGX in Q4 2016 and has held it in 37 quarters since. The position peaked at $40K in Q4 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Pflug Koory held 115 shares of Quest Diagnostics worth $22.5K as of Q1 2026.
- Pflug Koory left its Quest Diagnostics share count unchanged in Q1 2026.
- Quest Diagnostics made up 0.01% of Pflug Koory's portfolio in Q1 2026, its #284 holding.
- Pflug Koory first reported a position in Quest Diagnostics in Q4 2016 and has held it in 37 quarters since.
- Pflug Koory's Quest Diagnostics position peaked at $40K in Q4 2021.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.